ArticleBMC women's health2025
Prevalence and associated risk factors of bacterial vaginosis among women of reproductive age living with, and without HIV in Lagos, Nigeria.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundBacterial vaginosis (BV) is a vaginal dysbiosis of public health significance in reproductive-aged women. BV is associated with an increased risk of pelvic inflammatory disease, cervicitis, HIV infection and other obstetric complications like premature rupture of membranes, preterm labour and post-partum endometritis. This study aimed to determine the prevalence and risk factors of BV among women of childbearing age living with, and without HIV in Nigeria.
methodsThis was a cross-sectional study conducted among non-pregnant women of childbearing age (18-49 years), living with and without HIV in Lagos, Nigeria. Participants were counselled and informed consent was obtained before vaginal swabs were collected. BV was defined using Amsel’s criteria, which uses 3 out of 4 diagnostic criteria to diagnose BV and Nugent scoring. Data analysis was done using Statistical Package for Social Sciences (SPSS) version 27.0.
resultsTwo hundred and fifty-two (252) women of childbearing age including 198 (78.6%) living with HIV (WLHIV), and 54 (21.4%) without HIV were included in the study. The mean age was 41 ± 6 years with a range from 21 to 49 years. The overall prevalence rate of BV was 36.1%. Prevalence of BV was higher in WLHIV (37.9%) compared to those without HIV (29.6%) although this was not statistically significant (OR = 1.36; 95% CI: 0.67 – 2.79). Prevalence of BV among HIV-positive women with CD4 > 200 cells/mm3 was 36.9%, as against 54.5% for those whose CD4 was ≤ 200 cells/mm3 (OR = 1.40; 95% CI: 0.33–5.96). Having more than one sexual partner predisposed the women to BV (OR = 1.89; 95% CI: 1.01–3.53) while women who douche had a 1.7-fold increased risk of having BV than those who do not (OR = 1.65; 95% CI: 0.95- 2.88).
conclusionThe findings of this study indicate that women of reproductive age are equally susceptible to BV irrespective of their HIV status, with multiple sexual partners identified as a significant risk factor. These results underscore the need for targeted public health interventions aimed at reducing the prevalence of BV within this population, thereby reducing the risk of transmission of HIV and other sexually transmitted disease among this group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.